Last reviewed · How we verify
Quadrivalent VLP Vaccine
This quadrivalent VLP vaccine induces an immune response against four different strains of the influenza virus.
This quadrivalent VLP vaccine induces an immune response against four different strains of the influenza virus. Used for Influenza prevention.
At a glance
| Generic name | Quadrivalent VLP Vaccine |
|---|---|
| Sponsor | Medicago |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
The vaccine uses virus-like particles (VLPs) to stimulate the body's immune system, producing antibodies that can recognize and neutralize the influenza virus. This provides protection against infection and reduces the severity of symptoms if the virus is contracted.
Approved indications
- Influenza prevention
Common side effects
- Injection site pain
- Fatigue
- Headache
Key clinical trials
- Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial (PHASE3)
- Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015) (PHASE3)
- Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old (EARLY_PHASE1)
- Long Term Follow-up of HPV Vaccine in HIV (CTN 236)
- Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
- HPV Vaccine Immunity in High-risk Women (PHASE4)
- Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults (PHASE3)
- Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Quadrivalent VLP Vaccine CI brief — competitive landscape report
- Quadrivalent VLP Vaccine updates RSS · CI watch RSS
- Medicago portfolio CI